HYPERICIN-PVP KOMPLEX MIT HOHEM HYPERICINANTEIL

European patent · EP3820524 · In force

Register entry

Publication number
EP3820524
Application number
EP19736763
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 12, 2019
Published
May 19, 2021
Granted
Sep 6, 2023
Protection ends at the latest
Jul 11, 2039
Next annual fee due
Jul 31, 2027
IPC classes
A61K 47/58 (2017.01)
A61K 41/00 (2020.01)
A61P 35/00 (2006.01)
Priority
EP 18183435 13.07.2018
PCT application
PCT/EP2019/068775 12.07.2019
PCT publication
WO2020/011960 16.01.2020
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 5, 2024

    Change

    Published in Swissreg on 05.08.2024

  4. Jul 17, 2024

    Change

    Published in Swissreg on 17.07.2024

  5. Oct 6, 2023

    Agent entered

    Representative
    RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich

    Published in Swissreg on 06.10.2023

  6. Sep 6, 2023

    Granted

    Published in Swissreg on 06.09.2023

Parties

Holder

Hypericum Lifescience GmbH

Erlgasse 48/2, 1120 Wien, AT

Agent

RENTSCH PARTNER AG

Kirchenweg 8 Postfach, 8034 Zürich

Inventor

KUBIN, Andreas

1120 Wien, AT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.